Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Ironwood Pharmaceuticals, Inc. (NAS: IRWD) will present a corporate update at the 31st Annual J.P. Morgan Healthcare Conference on Monday, January 7, 2013 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time at the Westin St. Francis Hotel in San Francisco. The presentation will be followed by a question and answer session that will begin at approximately 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time.
A live webcast of Ironwood's presentation and the question and answer session will be accessible through the Investors section of the company's website at www.ironwoodpharma.com. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwood's website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NAS: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Ironwood is located in Cambridge, Mass. To learn more, visit www.ironwoodpharma.com.
Ironwood Pharmaceuticals, Inc.
Media Relations
Lisa Buffington, 617-374-5103
Vice President, Corporate Communications
lbuffington@ironwoodpharma.com
or
Investor Relations
Meredith Kaya, 617-374-5082
Associate Director, Investor Relations
mkaya@ironwoodpharma.com
KEYWORDS: United States North America California Massachusetts
INDUSTRY KEYWORDS:
The article Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
